REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 184 filers reported holding REGENXBIO INC in Q4 2018. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $554 | -100.0% | 27,700 | -57.9% | 0.00% | -66.7% |
| Q1 2021 | $2,244,000 | -87.5% | 65,779 | -81.2% | 0.00% | -81.2% |
| Q2 2019 | $18,002,000 | -63.9% | 350,441 | -59.7% | 0.02% | -64.4% |
| Q1 2019 | $49,845,000 | +34.3% | 869,741 | -1.7% | 0.04% | +9.8% |
| Q4 2018 | $37,123,000 | +71.6% | 884,943 | +208.9% | 0.04% | +86.4% |
| Q3 2018 | $21,631,000 | +440.0% | 286,500 | +113.5% | 0.02% | +1000.0% |
| Q2 2018 | $4,006,000 | 0.0% | 134,200 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $4,006,000 | – | 134,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,167,684 | $28,842,000 | 9.84% |
| Sonic Fund II, L.P. | 193,079 | $4,769,000 | 2.91% |
| ArchPoint Investors | 253,181 | $6,254,000 | 2.48% |
| Redmile Group, LLC | 2,004,663 | $49,515,000 | 1.89% |
| Sofinnova Investments, Inc. | 776,624 | $19,183,000 | 1.60% |
| RTW INVESTMENTS, LP | 1,845,366 | $45,581,000 | 1.18% |
| WS MANAGEMENT LLLP | 416,997 | $10,300,000 | 0.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,129 | $2,572,000 | 0.79% |
| HARBOR CAPITAL ADVISORS, INC. | 30,251 | $747,000 | 0.57% |
| Atom Investors LP | 36,487 | $901,000 | 0.39% |